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Abstract
Background: Surgical treatment and its consequences expose patients to stress, and here we
investigated the importance of the psychological component of postoperative pain based on
reports in the clinical literature.
Discussion: Postoperative pain remains a significant clinical problem. Increased pain intensity with
increased demand for opioid medication, and/or a relative unresponsiveness to pain treatment was
reported both when the analgesia was administered by means of conventional nurse injection
regimes and patient-controlled analgesia (PCA). Both the quality of the analgesia, and the sensitivity
of postoperative models for assessing analgesic efficacy could be significantly influenced.
The findings could be explained by increased penetration of an algesic anxiety-related nocebo
influence (which we chose to call "anxiebo") relative to its analgesic placebo counterpart. To
counteract this influence, the importance of psychological effects must be acknowledged, and
doctors and attending nurses should focus on maintaining trustful therapist-patient relationships
throughout the treatment period. The physical mechanism of anxiebo should be further explored,
and those at risk for anxiebo better characterized. In addition, future systemic analgesic therapies
should be directed towards being prophylactic and continuous to eliminate surgical pain as it
appears in order to prevent the anxiebo effect.
Addressing anxiebo is the key to developing reproducible models for measuring pain in the
postoperative setting, and to improving the accuracy of measurements of the minimum effective
analgesic concentration.
Summary: Anxiebo and placebo act as counterparts postoperatively. The anxiebo state may
impair clinical analgesia and reduce the sensitivity of analgesic trials. Ways to minimize anxiebo are
discussed.
Background
In spite of considerable progress in postoperative analge-
sia, recent studies show that adequate pain relief remains
elusive for a significant fraction of hospitalized surgical
patients [1-3]. Continuous awareness of this problem and
further efforts to improve treatment are required despite
the availability of acute pain services [3]. Surgical treat-
ment and its consequences cause psychological stress, and
pain intensity after surgery is influenced by both analgesic
drug effects and psychological factors. These factors
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comprise on the one hand an analgesic placebo influence
induced by the therapeutic situation per se, and on the
other hand its clinically less studied algesic anxiety-related
nocebo influence counterpart [4-6] (in this article the
term "anxiebo" is used to better focus on how to deal with
this connection clinically).
The clinical effects of anxiebo have been only incom-
pletely evaluated. In this work, relevant reports in the lit-
erature were assessed with regard to evidence of anxiebo,
and its clinical expressions are described here. Implica-
tions of the findings on clinical practice, development of
analgesic drugs, and assay sensitivity of clinical trials are
discussed.
Discussion
The anxiebo-placebo relationship
The levels of perceived self-control (self-efficacy) and
anticipatory anxiety are important factors in determining
whether somebody will be a placebo or anxiebo
responder [7-9], and may be influenced by the presence or
absence of supportive social interaction. In this respect,
the central role of the therapist/patient relationship
should be recognized. Anxiebo may result from either a
lack of supportive social interaction or inherently weak
self-control in connection with exposure to painful stim-
uli (Figure 1). The lower the overall experience of control,
the stronger the reported anticipatory anxiety, the pain
experience expressed as pain-intensity ratings, and the
autonomic activation.
The effects of anxiebo and placebo can be clearly visual-
ised on PET scans of the brain [9]. During placebo analge-
sia the activity patterns in the brain, brainstem and
descending antinociceptive systems demonstrate that the
endogenous opioid system is activated, and there are indi-
cations that the placebo state is sensitive to the effects of
morphine [9,10]. These findings suggest that a placebo
patient under opioid treatment should be able to closely
approach a pain-free state. In anxiebo, on the other hand,
scan findings indicate that the sensitivity to opioids is
reduced but not abolished [9,11].
Reviews of analgesic trial outcomes have indicated that
the degree of pain relief obtained may range between 0
and 100 per cent both for placebo and active drug patients
[12,13]. A plausible explanation for this is that placebo
and anxiebo act reciprocally and that the degree of shift in
either direction is determined by how psychological ele-
ments of the analgesia are handled.
Factors influencing postoperative anxiebo or placebo Figure 1
Factors influencing postoperative anxiebo or placebo.
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Evidence of anxiebo in postoperative analgesia
A combination of nonopioid analgesics and opioids is
most often used to achieve postoperative analgesia, and
the opioids are frequently administered by nurse-admin-
istered injections. Delay between need and injection con-
stitutes the major problem with this approach [2]. Classic
references indicate that preoperative encouragement and
preparation of patients receiving nurse injections may
decrease their opioid dosage by 50% [14,15], and directed
patient information and psychological support are advo-
cated. There is a moderate correlation between variable
degrees of anxiety on the one hand, and pain intensity
and requirement for opioid analgesics on the other, and
these effects appear not only when the opioid injections
are administered by an attendant nurse but also in
patient-controlled analgesia (PCA) [16], where the access
to intermittent doses of opioid should not be a limitation.
While morphine at low doses is used as an anxiolytic, a
deeper analysis of this effect, for instance with regard to
the dose-response relationship and individual variation,
appears to be lacking. Other approaches to reducing anx-
iety include the preoperative use of benzodiazepine [17]
or distracting the patient, for instance by exposure to
music [18]. Furthermore, a study of dental out-patients
has suggested that a postoperative telephone call from the
therapist demonstrating care and reassurance may
improve the analgesia [19].
Several studies indicate that a significant fraction of PCA
patients experiences moderate or severe pain [1,3].
Regional nerve blocks – which also require more doctor-
patient interaction – on average produce clearly better
results than systemic opioid techniques [2]. Even consid-
ering pain components that are known to be opioid resist-
ant, the only way of explaining why timely treatment with
systemic opioids should leave a proportion of patients
with these levels of residual pain is by implicating a degree
of anxiebo. This link is further confirmed by a controlled
study that showed that PCA in the early phase after knee
surgery (performed under general anesthesia) was associ-
ated with low oxygen tension in the subcutis, while a nor-
mal tension was observed after more-effective regional
analgesia [20]. These findings indicate different levels of
psychological stress and sympathetic tone in the two
patient groups, and the oxygen tension in the group that
received only the less-effective opioid analgesia was so
low that it predisposed to surgical wound infection.
Studies into the use of PCA lend themselves also to further
evaluation because of the considerable use of PCA as a
research technique for assessing analgesic efficacy. There
are many indications in the literature that PCA functions
well as an analgesic method and that the patient-control
concept is accepted by the patients. However, the question
of control may be difficult to assess in a clinical situation
involving an element of dependence. Recent reports show
that many PCA patients do not recognize themselves as
being in control of their treatment, and they may experi-
ence side effects and fear on utilization that limit their
ability to control pain [21,22]. It is well known also from
other studies that several psychological parameters are
predictors of pain and/or opioid use (i.e. the propensity to
press the controlling button) in PCA [16], of which anxi-
ety-related factors are common. Thus, the connection
between anxiebo and opioid use may explain why 20% of
patients using PCA were found to press the analgesic-
delivery button at an unchanged rate when the injected
opioid dose was decreased [23]. Against this background,
the findings in 18 trials assessing the efficacy of continu-
ous basal or therapeutic infusions of opioid in connection
with PCA are of interest. In the two largest studies [24,25],
the addition of infusions at different rates did not reduce
pain intensity, while the injected PCA dosages were clearly
reduced in one study but not in the other. The remaining
(smaller) studies demonstrated neither clinically convinc-
ing reductions in PCA dosage nor reductions in pain
intensity that might be of general importance. Assuming
full sensitivity to the continuously administered opioid,
one should have expected the pain intensity to approach
zero with increasing dosage, and as a result reproducible
decreases in PCA analgesic dosage. The findings indicate
that the assumption that the patients titrate to a common
pain intensity level, and adapt their injection rates to an
added analgesic stimulus, may have important limita-
tions. It is therefore reasonable to implicate anxiebo in
these examples of remarkable and long-lasting unrespon-
siveness to a continuous dosage of opioid. The underlying
causes of these indications of poor sensitivity to the effect
of opioids have, to our knowledge, not been further
explored in the clinical literature.
In PCA, it is logical that the combination of an anxiebo-
induced decrease in opioid sensitivity and an increase in
the rate of self-administration as part of a coping reaction
to anxiebo may in certain patients lead to pronounced
overuse of morphine that is unrelated to the need for
analgesia.
Implications for therapy, drug development, and research
The observations above indicate that both nurse injection
regimes and PCA may produce signs of anxiebo character-
ized by increased pain intensity with increased demand
for opioid medication, and/or a relative unresponsiveness
to pain treatment, which may last for days (Figure 2).
Avoiding anxiebo and thereby promoting placebo thus
appears to be an important component of effective anal-
gesic treatment. In order to accomplish this, the central
role of a trustful therapist-patient relationship (doctor
and nurse vs patient) throughout the treatment period
should be recognized. Assuming that anxiebo could beBMC Anesthesiology 2005, 5:9 http://www.biomedcentral.com/1471-2253/5/9
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eliminated clinically, the placebo state would be more
prevalent, although its maximal overall influence in terms
of improving the outcome of opioid treatment cannot yet
be judged.
It is likely that the direct caregiver-patient relationship in
nurse injection regimes can be used to better advantage,
and minimizing stressful break-through pain should be
emphasized. With regard to PCA, we do not doubt its role
when applied in a suitable, psychologically supportive
environment, but the method is more complex than gen-
erally thought. For those patients who do not adapt to the
control concept, and respond with signs of anxiebo, extra
support may be required or alternative treatment should
be sought.
Conceptually, it would appear advantageous to direct
future systemic analgesic therapies towards being prophy-
lactic and continuous (partly to eliminate surgical pain as
it appears, and partly to prevent the anxiebo effect) rather
than reactive and intermittent. By analogy, the use of con-
tinuously acting psychotropic drugs that specifically coun-
teract elements of the anxiety state may be effective in
patients who respond poorly to analgesia.
The mechanisms underlying anxiebo should be further
explored and other measures aimed at reducing anxiebo
should be examined. In particular, further efforts should
be devoted to defining patient groups and individuals that
are especially at risk. This may be done by developing eas-
ily applicable scales for identifying at-risk patients
Reciprocal effects of anxiebo and placebo in postoperative patients Figure 2
Reciprocal effects of anxiebo and placebo in postoperative patients. The propensity for a fraction of patients with 
patient-controlled analgesia (PCA) to press the analgesic-delivery button for reasons unrelated to pain may reflect a coping 
mechanism.
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preoperatively, and by preparing these patients with suit-
able information. Techniques should be sought which
allow postoperative diagnosis of anxiebo. We suggest that
perceived expectancy of future pain as opposed to subjec-
tive estimates of current pain may be a parameter of inter-
est for better predicting a patient's risk for the anxiebo
effect.
While the drug placebo effect is regularly accounted for in
clinical trials, the effect of its anxiebo counterpart is not. It
appears likely that trial assay sensitivity is reduced with
variable penetration depending on the specific therapeu-
tic circumstances of the individual study. Anxiebo may
result in false-negative or borderline results, as indicated
above for PCA models. Such systemic errors are not
removed by simply increasing the size of the trial. The key
to a reproducible, sensitive model is the proper handling
of individual factors interacting within the psychological
context, with respect for the therapist-patient relationship.
Education and support to personnel handling the patients
postoperatively seems to be the critical factor. Optimally,
the anxiebo effect should be accounted for, perhaps by
conducting a preliminary sensitivity test using a drug
(such as morphine) with known analgesic effects.
Since patients or patient groups receiving PCA may not
titrate their opioid dosage (Figure 2), it follows that the
general usability of the clinical concept of minimum effec-
tive analgesic concentration as a guide for dosage can be
questioned in particular studies.
Summary
The importance of psychological reactions are commonly
acknowledged in postoperative analgesia, but the way
these reactions express themselves and the degree of dis-
turbance they may cause by producing anxiebo rather
than placebo states are at present incompletely consid-
ered. Maintaining trustful therapist-patient relationships
throughout the treatment period is very important. Future
systemic analgesic therapies should be directed towards
being prophylactic and continuous to eliminate surgical
pain as it appears so as to prevent the anxiebo effect. The
physical mechanism of anxiebo should be further
explored, and more effort made to define patient groups
and individual patients especially at risk. Addressing anx-
iebo is of importance also in the development of repro-
ducible models for assessing analgesic efficacy in the
postoperative setting, and may improve the accuracy of
measurements of the minimally effective analgesic
concentration.
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